CTLA4 and melanoma: In several tumors, such as melanoma, the expression levels of TIGIT in CD8+ T cells are upregulated, and the high TIGIT/DNAM1 ratio in Tregs is associated with poor prognosis following PD-1 and/or CTLA4 pathway blockade [43, 44].